www.businesswire.com Open in urlscan Pro
23.205.253.189  Public Scan

Form analysis
1 forms found in the DOM

Name: bw-search-form — POST /portal/site/home/template.SINGLEPORTLET/action.process/permalink/?javax.portlet.action=true&currentTemplateID=PAGE&javax.portlet.tpst=503a8767054f0df6a9e77a100d908a0c&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken

<form id="bw-search-form" name="bw-search-form"
  action="/portal/site/home/template.SINGLEPORTLET/action.process/permalink/?javax.portlet.action=true&amp;currentTemplateID=PAGE&amp;javax.portlet.tpst=503a8767054f0df6a9e77a100d908a0c&amp;javax.portlet.begCacheTok=com.vignette.cachetoken&amp;javax.portlet.endCacheTok=com.vignette.cachetoken"
  method="post">
  <fieldset>
    <div id="bw-search-options">
      <h3 id="bw-search-options-head" class="toggler hidden"><span>Search Options</span></h3>
      <div id="bw-search-filter-links" class="togglee">
        <ul>
          <li><a href="#?type=all" id="bw-search-filter-all" title="Search All" class="is-selected">Search All</a></li>
          <li><a href="#?type=news" id="bw-search-filter-news" title="Search News">Search News</a></li>
          <li><a href="#?type=site" id="bw-search-filter-site" title="Search Site">Search Site</a></li>
          <li>
            <a href="/portal/site/home/search?javax.portlet.tpst=503a8767054f0df6a9e77a100d908a0c&amp;javax.portlet.pbp_503a8767054f0df6a9e77a100d908a0c_view=advancedSearch&amp;javax.portlet.begCacheTok=com.vignette.cachetoken&amp;javax.portlet.endCacheTok=com.vignette.cachetoken" id="bw-search-filter-adv" title="Advanced News Search">Advanced News Search</a>
          </li>
        </ul>
      </div>
    </div>
    <label for="bw-search-input">Advanced News Search</label>
    <input type="search" id="bw-search-input" name="q" maxlength="256" value="" title="Search BusinessWire.com" placeholder="Search">
    <input type="hidden" id="bw-search-type" name="qSearchType" value="all">
    <button type="submit" class="bw-button-primary" id="bw-search-button" title="Search"><span><img src="/images/icons/icon_search.gif" alt="Search"></span></button>
  </fieldset>
</form>

Text Content

JUSTIN MIKA JOINS PHENOVISTA BIOSCIENCES’ BOARD OF ADVISORS

Mika will help guide PhenoVista’s leadership in the company’s new phase of
growth.

November 22, 2022 03:30 PM Eastern Standard Time

SAN DIEGO--(BUSINESS WIRE)--PhenoVista Biosciences, a leading provider of
advanced phenotypic discovery services, announced today that Justin Mika has
joined their Board of Advisors. Mr. Mika has helped lead growth-oriented
biotechnology and contract research organizations for over 15 years. At
PhenoVista, Mr. Mika will leverage his extensive experience to guide the
company’s leadership team as they drive operational efficiency and sustainable
growth.

> “PhenoVista stands out in the field of phenotypic drug discovery with its
> ability to develop complex cell models and deliver high-content imaging and
> analysis. I look forward to partnering with them to realize the enormous
> impact they can have on the industry and, ultimately, on patients”
> 
> Tweet this

“We’re very fortunate to bring Justin onto our Board of Advisors. Justin has a
wealth of hands-on experience running and improving the efficiency of service
companies like ours,” said James G. Evans, CEO and co-founder of PhenoVista.
“Our leadership team and Justin share common values and beliefs, most notably
that our clients deserve the highest-quality data and customer service in the
shortest time possible so they can more rapidly innovate the next generation of
therapies and cures. Justin will help the entire PhenoVista team focus on
partners, innovation, and scale to drive growth and improve services for our
customers as they resolve to impact global health.”

“PhenoVista stands out in the field of phenotypic drug discovery with its
ability to develop complex cell models and deliver high-content imaging and
analysis. I look forward to partnering with them to realize the enormous impact
they can have on the industry and, ultimately, on patients,” said Mr. Mika.

Mr. Mika was most recently Chief Executive Officer of AlivaMab Discovery
Services (ADS) where he grew a world-class antibody-discovery and engineering
organization from eight people to over 50 in less than three years. Prior to
ADS, Justin was Senior Vice President of the Eurofins Drug Discovery Division
where he was responsible for setting strategic direction across nine global
locations. He was also General Manager and Chief Commercial Lead of DiscoverX,
which was acquired in 2017. Mr. Mika earned his Bachelor of Science in
Biochemistry and Molecular Biology at Pennsylvania State University and his MS
and MBA at the University of Delaware.

About PhenoVista Biosciences

PhenoVista Biosciences is a leading provider of advanced phenotypic assay
services based in San Diego, California. PhenoVista’s team of PhD-level
scientists with diverse expertise, ranging from biomedical engineering to
neurobiology, work with clients in a collaborative, adaptable manner to design
and implement physiologically meaningful assays that are more predictive of drug
safety and efficacy. PhenoVista has built a strong reputation on providing
high-quality data to biopharmaceutical clients with its unique and unparalleled
combination of cutting-edge cell models and the latest quantitative-imaging
technologies and data-analysis capabilities. Their diverse repertoire includes
working with primary cells, iPSC-derived neurons and glia, and client-engineered
lines in a variety of formats, such as 2D, 3D, co-culture, and microfluidic
systems. PhenoVista’s team delivers unrivaled functional, structural, and
pre-clinical, mechanistic data to clients globally.

For more information, please visit www.PhenoVista.com.


CONTACTS

James G. Evans, PhD
CEO
PhenoVista Inc.
Contact@phenovista.com


PHENOVISTA BIOSCIENCES




MORE NEWS

 * March 03, 2022
   PhenoVista Biosciences Announces Michelle Mack as VP of Business Development
 * January 18, 2022
   PhenoVista Biosciences Raises Growth Capital From BroadOak Capital Partners


CONTACTS

James G. Evans, PhD
CEO
PhenoVista Inc.
Contact@phenovista.com




SITE NAVIGATION

 * Home
   * Home
   * Submit a Press Release
 * Services
 * News
   * All News
   * News with Multimedia
   * News by Industry
   * News by Subject
   * News by Language
   * Tradeshows & Events
 * Education
   * Overview
   * Blog
   * Distribution & Media
   * Media & Journalist Tools
   * Sample Press Release
   * Find Your News Online
   * Disclosure Resources
 * About Us
   * Overview
   * Become a Member
   * Contact Us
   * Careers
   * Business Wire Newsroom
   * Business Wire Events


SEARCH


SEARCH OPTIONS

 * Search All
 * Search News
 * Search Site
 * Advanced News Search

Advanced News Search
 * Log In
 * Sign Up


FOLLOW US

 * Twitter
 * LinkedIn


MORE FROM BUSINESS WIRE

 * Blog
 * UK/Ireland
 * Deutschland
 * France
 * Hong Kong
 * Italy
 * Japan
 * Tradeshownews.com


BUSINESS WIRE INFORMATION

 * Contact Us
 * UK Tax Strategy
 * Privacy Statement
 * Manage Cookies
 * Terms of Use
 * © 2022 Business Wire

Internet Explorer presents a security risk. To ensure the most secure and best
overall experience on our website we recommend the latest versions of Chrome,
Edge, Firefox, or Safari. Internet Explorer will not be supported as of August
17, 2021. Internet Explorer is no longer supported. To ensure the most secure
and best overall experience on our website, we recommend the latest versions of
Chrome, Edge, Firefox, or Safari.


PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer. More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active
Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

Cookies Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

Cookies Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

Cookies Details‎

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

Cookies Details‎

SOCIAL MEDIA COOKIES

Social Media Cookies

These cookies are set by a range of social media services that we have added to
the site to enable you to share our content with your friends and networks. They
are capable of tracking your browser across other sites and building up a
profile of your interests. This may impact the content and messages you see on
other websites you visit. If you do not allow these cookies you may not be able
to use or see these sharing tools.

Cookies Details‎
Confirm My Choices

Back Button

Back


PERFORMANCE COOKIES

Vendor Search Search Icon Filter Icon


Clear Filters

Information storage and access
Apply
Consent Leg.Interest

All Consent Allowed

Select All Vendors
Select All Vendors
All Consent Allowed


 * 33ACROSS
   
   HOST DESCRIPTION
   
   VIEW COOKIES
   
   
   REPLACE-WITH-DYANMIC-HOST-ID
    * Name
      cookie name


 * 33ACROSS
   
   View Privacy Notice
   
   3 Purposes
   
   REPLACE-WITH-DYANMIC-VENDOR-ID
   Arrow
   
   Consent Purposes
   
   Location Based Ads
   
   Consent Allowed
   
   Legitimate Interest Purposes
   
   Personalize
   
   Require Opt-Out
   
   Special Purposes
   
   Location Based Ads
   
   Features
   
   Location Based Ads
   
   Special Features
   
   Location Based Ads

Confirm My Choices


By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts. Cookie Policy

Cookies Settings Accept All Cookies

 * Share
 * Share
 * Tweet
 * Mail
 * Share
 * Copy
 * Share